title: Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.
abstract: Endotoxin syndrome is a systemic inflammatory response mediated by inflammatory cytokines. Nuclear factor kappa B (NF-kappa B) is the dominant regulator of the production of these cytokines by inflammatory cells. The aim of this study was to assess the efficacy of in vivo transfer of synthetic double-stranded oligodeoxynucleotides (ODN) with high affinity against NF-kappa B (NF-kappa B/decoy/ODN) as a therapeutic strategy for treating endotoxin-induced fatal liver injury. Liver injury was induced by administration of lipopolysaccharide (LPS) to Propionibacterium acnes-primed BALB/C mice. NF-kappa B/decoy/ODN was transferred into the portal vein using a fusigenic liposome with hemagglutinating virus of Japan. NF-kappa B/decoy/ODN was preferentially transferred to Kupffer cells, and activation of NF-kappa B after the LPS challenge was suppressed, leading to decreased inflammatory cytokine production. As a result, the massive necrosis and hepatocyte apoptosis observed in the control mice was dramatically attenuated and the survival rate improved. In conclusion, NF-kappa B/decoy/ODN transfer in vivo effectively suppressed endotoxin-induced fatal liver injury in mice.
authors.affiliation: First Department of Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
authors.forename: Ichiro
authors.initials: I
authors.lastname: Ogushi
authors.forename: Yuji
authors.initials: Y
authors.lastname: Iimuro
authors.forename: Ekihiro
authors.initials: E
authors.lastname: Seki
authors.forename: Gakuhei
authors.initials: G
authors.lastname: Son
authors.forename: Tadamichi
authors.initials: T
authors.lastname: Hirano
authors.forename: Toshikazu
authors.initials: T
authors.lastname: Hada
authors.forename: Hiroko
authors.initials: H
authors.lastname: Tsutsui
authors.forename: Kenji
authors.initials: K
authors.lastname: Nakanishi
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Morishita
authors.forename: Yasufumi
authors.initials: Y
authors.lastname: Kaneda
authors.forename: Jiro
authors.initials: J
authors.lastname: Fujimoto
mesh_terms: D000818:Animals; D017209:Apoptosis; D004195:Disease Models, Animal; D053222:Fas Ligand Protein; D016650:Fluorescein-5-isothiocyanate; D005456:Fluorescent Dyes; D015316:Genetic Therapy; D022781:Hepatocytes / Q000473:pathology; D007375:Interleukin-1 / Q000096:biosynthesis; D018664:Interleukin-12 / Q000096:biosynthesis; D020382:Interleukin-18 / Q000096:biosynthesis; D007728:Kupffer Cells / Q000378:metabolism; D008070:Lipopolysaccharides; D017093:Liver Failure / Q000473:pathology / Q000517:prevention & control* / Q000628:therapy*; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics; D051379:Mice; D008807:Mice, Inbred BALB C; D016328:NF-kappa B / Q000235:genetics* / Q000378:metabolism; D009336:Necrosis; D009838:Oligodeoxyribonucleotides / Q000494:pharmacology*; D011401:Promoter Regions, Genetic; D011425:Propionibacterium acnes; D051996:Transcription Factor RelA; D014162:Transfection; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D005456:Fluorescent Dyes; D007375:Interleukin-1; D020382:Interleukin-18; D008070:Lipopolysaccharides; D008562:Membrane Glycoproteins; D016328:NF-kappa B; D009838:Oligodeoxyribonucleotides; D051996:Transcription Factor RelA; D014409:Tumor Necrosis Factor-alpha; D018664:Interleukin-12; D016650:Fluorescein-5-isothiocyanate